Euflexxa 2ml

Description

Euflexxa 2ml: Treatment Guidelines

Prior to Treatment:

• If joint effusion is present, it should be removed using a separate syringe prior to administering Euflexxa 2ml.
• Administer Euflexxa 2ml intra-articularly (into the joint space) in each affected knee.
• The entire contents of the syringe (2ml) should be injected into each knee.
• This process is repeated weekly for 3 weeks, with each knee receiving a separate injection using separate syringes.

Important Considerations:

• Age Limitation: Euflexxa 2ml is not recommended for use in children.
• Repeated Treatment Cycles: The frequency and necessity of repeated treatment cycles have not been firmly established.
• Injection Technique: Care should be taken to avoid intravascular injection to minimize potential complications.
• Post-Injection Precautions: Patients are advised to avoid strenuous activity for at least 48 hours following each injection.
• Special Populations: Euflexxa 2ml should be avoided during pregnancy and breastfeeding.
• Disinfectants: Products containing quaternary ammonium salts should not be used as disinfectants in conjunction with Euflexxa 2ml injections.
• Concomitant Injections: Simultaneous use of other intra-articular injectables with Euflexxa 2ml is not recommended due to potential interactions or interference with efficacy.

Summary: Euflexxa 2ml is intended for intra-articular injection to treat affected knees in patients with joint-related issues. It requires a specific protocol of weekly injections for three weeks per knee. Adherence to injection technique, precautions, and avoidance of certain agents are crucial for the safe and effective use of Euflexxa 2ml. Always consult healthcare professionals for personalized guidance and monitoring during treatment.